Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 875 across all filing types
Latest filing 2018-09-28 Board/Management Inform…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Valberedningens ledamöter inför Episurf Medicals årsstämma 2019
Board/Management Information Classification · 99% confidence The document text is titled "Valberedningens ledamöter inför Episurf Medicals årsstämma 2019" (Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2019). It details the composition, appointment process, and contact information for the Nomination Committee, which is responsible for proposing candidates for the board ahead of the Annual General Meeting (AGM). This content directly relates to the governance and preparation for the AGM, specifically concerning board nominations. This aligns best with Governance Information (CGR), as it details internal rules/structure related to board appointments, although it is closely related to AGM materials. Given the specific focus on the Nomination Committee structure and members, CGR (Governance Information) is the most appropriate fit over AGM-R (which usually implies the meeting presentation itself) or DEF 14A (which focuses on remuneration).
2018-09-28 Swedish
Members of the Nomination Committee for Episurf Medical’s Annual General Meeting in 2019
AGM Information Classification · 98% confidence The document explicitly discusses the composition and members of the 'Nomination Committee for Episurf Medical's Annual General Meeting in 2019'. It details how members are appointed by shareholders and the Board Chairman, and mentions procedures for submitting proposals before the AGM. This content directly relates to the governance and preparatory materials for the Annual General Meeting (AGM). Therefore, the most appropriate classification is AGM Information (AGM-R). The document is not a full report (10-K, IR), a management change announcement (MANG), or a proxy statement (PSI), but specific information related to the AGM structure.
2018-09-28 English
Episurf Medical expanderar till polska marknaden
Regulatory Filings Classification · 95% confidence The document is a short announcement in Swedish regarding Episurf Medical's expansion into the Polish market through a local partnership and expected product registration. It details strategic growth activities and market potential. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a formal regulatory filing like a proxy statement (DEF 14A). Given its nature as a specific business update concerning market entry and strategy, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, as there is no specific category for 'Market Expansion Announcement'. It is too specific for RNS, but RNS is the best fit among the provided options for a non-standard, material business update that isn't covered by other specific codes (like CAP, MANG, or TAR). Since it is a material announcement, RNS is the appropriate fallback.
2018-09-27 Swedish
Episurf Medical expands into the Polish Market
Regulatory Filings Classification · 95% confidence The document announces that Episurf Medical is expanding into the Polish market through a local partnership and that product registration is in its final phase. It includes a quote from the CEO about the commercial opportunity. The text concludes with a statement that this information is 'obliged to make public pursuant to the EU Market Abuse Regulation' and was submitted for publication at a specific time. This structure strongly suggests a mandatory, timely regulatory disclosure that is not a full financial report (like 10-K or IR), nor a specific transaction report (like DIRS or POS). Since it is a general, material business update that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Dividend (DIV), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2018-09-27 English
Rättelse av pressmeddelande avseende förändring av antalet aktier och röster i Episurf Medical
Share Issue/Capital Change Classification · 99% confidence The document is a correction ('Rättelse') to a previous press release concerning a change in the number of shares and votes ('förändring av antalet aktier och röster'). It explicitly details the conversion of convertible notes, the resulting increase in shares (373,333), and the new total number of shares and votes. This directly relates to changes in the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers announcements regarding new share issues or capital changes. Although it is a correction, the core subject matter is a capital change event.
2018-08-31 Swedish
Correction of press release regarding change in number of shares and votes in Episurf Medical
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a correction to a previous press release concerning the conversion of convertible bonds, which resulted in an increase in the total number of shares and votes. It explicitly details the change in share count and total votes. This type of announcement, dealing with changes in the capital structure due to financing activities (conversion of debt to equity), fits best under 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). Since it details a change in the number of shares resulting from a financing event, CAP is the most appropriate classification over SHA (which usually covers splits or new issues not directly tied to debt conversion) or MRQ (which focuses on major shareholder ownership changes, not the company's own capital structure change via bond conversion). The document length is short, but its content is substantive regarding capital structure, making it a direct announcement rather than just an RPA.
2018-08-31 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.